FindTrial
Sign In

Efficacy and Safety of Endoscopic Mucosal Resection with a Cap (EMRC) for Duodenal Epithelial Tumors < 12 mm

Efficacy and Safety of Endoscopic Mucosal Resection with a Cap (EMRC) for Duodenal Epithelial Tumors < 12 mm - Efficacy and Safety of Endoscopic Mucosal Resection with a Cap (EMRC) for Duodenal Epithelial Tumors < 12 mm

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000060434
Enrollment
80
Registered
2026-01-21
Start date
2026-11-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

duodenal tumor

Interventions

EMRC will be performed for superficial duodenal tumors 12 mm or smaller.

Sponsors

NTT Medical Center Tokyo
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: SNADETs 12 mm or smaller in size

Exclusion criteria

Exclusion criteria: Lesions involving the major or minor duodenal papilla. Patients with a general condition not suitable for endoscopic treatment. Cases in which multiple lesions were resected in a single treatment session. Patients who did not provide informed consent to participate in this study.

Design outcomes

Primary

MeasureTime frame
R0 resection—

Countries

Japan

Contacts

Public ContactNao Takeuchi

NTT Medical Center Tokyo Department of Gastrointestinal Endoscopy

naotakeuchi0222@gmail.com03-3448-6111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026